| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $70,548,278 ) (Continued on the next page) |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K24AT009465 | Mentoring and Patient-Oriented Research in Integrative Medicine | 000 | 8 | NIH | 4/21/2026 | $139,701 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AG080842 | Role of LRP1 in Alzheimer’s disease | 001 | 4 | NIH | 4/10/2026 | $105,621 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AG080842 | Role of LRP1 in Alzheimer’s disease | 000 | 4 | NIH | 3/19/2026 | $712,409 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K23HL171855 | Mixed meal tolerance test elicited metabolite responses as novel markers of cardiometabolic risk | 000 | 3 | NIH | 6/16/2026 | $190,905 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01NS133187 | Targeting the FBXW7/PGC1 Pathway as a Therapeutic Strategy for Parkinson's Disease | 000 | 3 | NIH | 2/23/2026 | $651,774 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K08HL161259 | Regulation of endothelial cell phosphatidylserine in thrombosis | 000 | 5 | NIH | 2/27/2026 | $165,024 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HD116774 | Predicting the Effect of Obstetric Unit Closures on Maternal and Neonatal Outcomes | 000 | 2 | NIH | 6/19/2026 | $688,796 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL174549 | Strategies to Improve the Cardiovascular Health of Rural Working-Age Adults in the United States | 000 | 3 | NIH | 6/18/2026 | $690,585 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AG082016 | Wake-sleep Circuitry in Neurodegenerative Dementias | 000 | 3 | NIH | 4/13/2026 | $909,276 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK138503 | Integrating signals that control APOL1 gene expression and drive kidney disease | 000 | 13 | NIH | 1/12/2026 | $540,299 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K01HL161034 | Admixture Mapping of Coronary Heart Disease and Associated Metabolomic Markers | 000 | 4 | NIH | 3/31/2026 | $158,454 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | P01AI179405 | Lupus nephritis: novel insights in the pathogenesis and treatment | 001 | 3 | NIH | 3/24/2026 | $0 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | P01AI179405 | Lupus nephritis: novel insights in the pathogenesis and treatment | 000 | 3 | NIH | 1/22/2026 | $2,211,043 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01NR021686 | Leveraging SNAP Policies to Improve Cardiovascular Health in the United States | 000 | 3 | NIH | 5/19/2026 | $713,365 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL171101 | Rechargeable Anti-thrombogenic Films for Blood Contacting Applications | 001 | 3 | NIH | 3/24/2026 | $23,100 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL171101 | Rechargeable Anti-thrombogenic Films for Blood Contacting Applications | 000 | 3 | NIH | 2/18/2026 | $731,468 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK130929 | Corticosteroids to Reduce Inflammation in Severe Pancreatitis (CRISP) | 000 | 5 | NIH | 12/17/2025 | $380,380 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA258776 | Pan-Cancer characterization of 3’UTR somatic mutations controlling tumor immune evasion | 001 | 5 | NIH | 4/16/2026 | $56,402 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA258776 | Pan-Cancer characterization of 3’UTR somatic mutations controlling tumor immune evasion | 000 | 5 | NIH | 1/16/2026 | $507,623 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA258442 | Clinical characterization of Kidney Injury Molecule-1 (KIM-1) as a Biomarker in Renal Cell Carcinoma | 000 | 5 | NIH | 3/3/2026 | $424,605 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01NS122589 | Neuronal Circuit Controlling Sleep-Promoting Ventrolateral Preoptic Neurons | 000 | 5 | NIH | 1/19/2026 | $337,669 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01NS122589 | Neuronal Circuit Controlling Sleep-Promoting Ventrolateral Preoptic Neurons | 001 | 5 | NIH | 3/18/2026 | $37,518 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA272934 | WNT5a/ROR2-Mediated Hippo Pathway Activation in Prostate Cancer | 000 | 4 | NIH | 5/26/2026 | $395,509 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | P01AI177687 | Multi-Omics Analysis of Broadly Neutralizing Antibodies and Therapeutic Vaccination | 000 | 4 | NIH | 4/27/2026 | $1,500,997 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL171121 | Novel Role Of ACTN4 in Sodium Reabsorption and Salt-Sensitive Hypertension | 001 | 3 | NIH | 4/23/2026 | $21,034 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL171121 | Novel Role Of ACTN4 in Sodium Reabsorption and Salt-Sensitive Hypertension | 000 | 3 | NIH | 2/16/2026 | $666,100 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R00EY032181 | Epigenomic mechanisms regulating RGC survival and axon regeneration | 000 | 6 | NIH | 5/5/2026 | $249,998 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL167383 | Thiol Isomerases and Oxidant Stress in Thrombus Formation | 000 | 3 | NIH | 4/21/2026 | $656,455 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA257672 | Detection of PD-1 inhibitory signaling and its molecular relays in T cells: Implications for cancer immunotherapy | 001 | 4 | NIH | 4/16/2026 | $71,150 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA257672 | Detection of PD-1 inhibitory signaling and its molecular relays in T cells: Implications for cancer immunotherapy | 000 | 4 | NIH | 1/22/2026 | $640,361 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R21AG085089 | A lab-on-a-chip device for measuring multiple biochemical and biophysical biomarkers of Alzheimer’s disease | 000 | 3 | NIH | 3/26/2026 | $216,125 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA276107 | Control of cancer cachexia via stimulation of resolution of inflammation | 001 | 3 | NIH | 4/16/2026 | $69,170 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA276107 | Control of cancer cachexia via stimulation of resolution of inflammation | 000 | 3 | NIH | 1/13/2026 | $622,526 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK142807 | Mapping Mechanosensory Circuits from the Bladder to Barrington's Nucleus | 000 | 2 | NIH | 7/6/2026 | $786,840 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL161012 | Leveraging omics data to understand sleep health and its consequences among diverse Hispanics/Latinos | 000 | 5 | NIH | 6/12/2026 | $590,268 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01NS133226 | Central vs. Peripheral Mechanisms of Headache: Cortex, Thalamus, Dorsal Horn | 000 | 3 | NIH | 3/30/2026 | $419,283 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AG079799 | Molecular mechanisms of aging and accelerated aging in the human brain | 000 | 3 | NIH | 3/20/2026 | $182,997 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AG080598 | Using polygenic risk scores and omics to study how suboptimal sleep accelerates cognitive aging in diverse populations | 000 | 4 | NIH | 6/11/2026 | $893,712 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK136699 | Use of Modified mRNA for the Treatment of Diabetic Foot Ulceration | 000 | 3 | NIH | 3/6/2026 | $731,010 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | RC2DK142612 | A database of indirect calorimetry experiments for the study of energy homeostasis | 000 | 2 | NIH | 6/9/2026 | $830,288 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K99CA293268 | Deciphering the Transcriptomic Basis of Chemo Fog | 000 | 2 | NIH | 6/11/2026 | $135,513 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AA032418 | Innate immune dysregulation in alcohol-associated liver disease | 000 | 2 | NIH | 6/3/2026 | $670,649 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK145097 | APOL1 Nephropathy: Linking Genetics and Mechanisms | 000 | 7 | NIH | 7/1/2026 | $659,358 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK142743 | Selective brain-to-gut communication via transcriptionally-defined vagus-to-enteric neuron circuits | 000 | 1 | NIH | 3/18/2026 | $834,911 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK146795 | Adiponectin Signaling in Bladder Function | 000 | 1 | NIH | 4/24/2026 | $739,141 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R21AI199146 | Development of next generation spectinomycin analogs that evade modifying enzyme-based resistance and show enhanced potency against multidrug-resistant pathogens. | 000 | 1 | NIH | 6/30/2026 | $493,865 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA314254 | One-ended Break Repair in Mammalian Cells | 000 | 1 | NIH | 5/11/2026 | $524,110 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL185389 | Cardiac MRI Phenotyping of Coronary Microvascular Dysfunction | 000 | 1 | NIH | 6/12/2026 | $848,141 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | F32HL186556 | Investigating Inflammatory Pathways in Pulmonary Vascular Disease | 000 | 1 | NIH | 6/25/2026 | $92,476 |
|
